Strut Real Customer Outcomes: An Independent Review of Results, Costs, and Alternatives

What Strut Actually Sells

Strut offers compounded prescription medications across three categories: hair restoration, skin care, and sexual health. Each product combines FDA-approved active pharmaceutical ingredients into proprietary multi-ingredient formulations dispensed from a licensed compounding pharmacy.

Hair Loss Products

The hair loss line centers on topical finasteride-minoxidil combinations. Oral finasteride at 1 mg daily reduced hair loss progression in 83% of men over two years in the key trial that led to FDA approval [1]. Topical minoxidil 5% produced a mean increase of 18.6 hairs per cm² compared to 12.7 for the 2% formulation in a 48-week randomized trial [2]. Strut combines these two agents into a single topical solution, a formulation strategy that has gained traction across telehealth platforms. A 2022 meta-analysis of topical finasteride found comparable scalp DHT reduction to oral finasteride with lower serum DHT suppression, suggesting a potentially improved side-effect profile [3].

The rationale is sound. Combining a 5-alpha reductase inhibitor with a vasodilator addresses two distinct pathways in androgenetic alopecia simultaneously. What Strut has not published is any internal efficacy data, treatment completion rates, or standardized photography outcomes from its own patient population.

Skin Care Products

Strut's dermatology line includes compounded tretinoin formulations for acne and anti-aging, often paired with niacinamide or other adjuncts. Tretinoin remains the best-studied topical retinoid, with a Cochrane review confirming statistically significant improvement in fine wrinkles, roughness, and hyperpigmentation after 12 weeks of use [4]. For acne, a 12-week RCT (N=180) showed tretinoin 0.025% cream reduced inflammatory lesion count by 51% versus 29% for vehicle [5].

Sexual Health Products

The ED products contain sildenafil or tadalafil in compounded forms, sometimes combined with oxytocin or apomorphine. Sildenafil's efficacy is well-established: the original Goldstein et al. Trial (N=532) demonstrated improved erections in 69% of all attempts versus 22% for placebo [6]. Tadalafil 5 mg daily improved IIEF-EF domain scores by 6.0 points above placebo in the pooled LVHJ analysis [7].

Is Strut Legit? Evaluating the Business Model

Yes, Strut operates as a legitimate telehealth platform with a licensed compounding pharmacy. But "legitimate" and "optimal" are different questions. Understanding how 503A compounding pharmacies work helps frame what customers are actually receiving.

How 503A Compounding Works

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies can prepare custom medications for individual patients with valid prescriptions. These products are exempt from FDA premarket approval, which means the specific combination formulations Strut sells have not undergone the same regulatory review as commercially manufactured drugs [8]. The FDA has noted that compounded drugs "are not FDA-approved" and that the agency "generally defers to state authorities regarding the day-to-day oversight of state-licensed pharmacies."

This is not unusual for telehealth compounding platforms. Hims, Ro, and dozens of other DTC companies use the same regulatory pathway. The important distinction: individual ingredients like finasteride and tretinoin have strong FDA approval, but the specific multi-ingredient combinations and concentrations may differ from what was studied in clinical trials.

Prescriber Oversight

Strut uses asynchronous consultations. Patients complete a health questionnaire, upload photos if relevant, and a licensed physician reviews the submission. This model is standard across telehealth dermatology and sexual health platforms. A 2021 JAMA Dermatology study found that asynchronous teledermatology had diagnostic concordance rates of 71% to 83% compared to in-person visits [9]. The model works well for pattern-recognition conditions like androgenetic alopecia and mild-to-moderate acne. It works less well for complex or atypical presentations.

Customer Outcome Patterns: What the Reviews Actually Show

Strut does not publish aggregate outcome data, so evaluating results requires triangulating across independent review platforms, BBB filings, and the underlying pharmacology.

Positive Outcome Themes

Across Trustpilot and Google Reviews, the most consistent positive reports involve hair regrowth visible at 4 to 6 months and skin texture improvements at 8 to 12 weeks. These timelines align with what clinical pharmacology predicts. Finasteride requires 3 to 6 months to show measurable hair count changes [1], and tretinoin typically needs 8 to 12 weeks for visible anti-aging effects [4]. When customers report "it's working," the timeline usually matches the known pharmacokinetics of the active ingredients.

Satisfaction with the ordering process and delivery speed appears consistently high. Complaints about customer service responsiveness appear intermittently but do not dominate the review field.

Negative Outcome Themes

The most common negative reviews fall into three categories. First, side effects that are predictable and well-documented for the active ingredients (scalp irritation from topical minoxidil, dryness and peeling from tretinoin, headache from sildenafil). Second, cost concerns, particularly when customers compare compounded products to generic equivalents available at retail pharmacies. Third, billing and cancellation friction, a complaint common across subscription-model telehealth platforms.

A smaller but notable subset of negative reviews describe minimal results after 6+ months of hair loss treatment. This too aligns with clinical expectations. In the key finasteride trial, 17% of men on active treatment still showed progression of hair loss at two years [1]. Not every patient responds.

What the Reviews Cannot Tell You

Self-reported outcomes on review platforms carry known biases. The 2019 Pew Research Center survey on online reviews found that people with very positive or very negative experiences are disproportionately likely to leave reviews, creating a U-shaped distribution that underrepresents average outcomes [10]. Strut's review profile follows this pattern. Without standardized measurement (hair counts, lesion counts, IIEF scores) and controlled follow-up, customer reviews are directional at best.

Strut vs. Alternatives: How It Compares

Several telehealth platforms compete directly with Strut in hair, skin, and sexual health. The comparison turns on four variables: ingredient selection, compounding approach, price, and clinical support depth.

Strut vs. Hims/Hers

Hims and Hers offer both FDA-approved branded products and compounded alternatives. Their scale is larger, which generally means more physician availability and faster turnaround. Pricing is comparable for similar products. The key difference: Hims and Hers have published some internal outcome data. Hims reported that 90% of men using their finasteride-minoxidil topical spray maintained or increased hair density at 12 months based on internal photo review, though this was not published in a peer-reviewed journal.

Strut's compounded formulations may include different adjunct ingredients (niacinamide, biotin, saw palmetto extracts) depending on the product line. Whether these additions provide meaningful benefit beyond the primary active ingredients is debatable. A 2020 systematic review found insufficient evidence to recommend saw palmetto for androgenetic alopecia [11].

Strut vs. Generic Prescriptions

For a patient willing to visit a primary care physician or use a telehealth platform that prescribes standard generics, the cost comparison shifts significantly. Generic finasteride 1 mg costs $3 to $15 per month at most retail pharmacies with a GoodRx coupon. Generic tretinoin 0.025% cream runs $20 to $40 for a 45g tube. Generic sildenafil 20 mg is $1 to $2 per tablet. A combined Strut subscription for similar ingredients may cost $50 to $95 per month.

The value proposition for Strut (and compounding telehealth broadly) rests on convenience, the combination formulation approach, and the bundled physician oversight. For patients who prefer a single subscription with a single shipment and no pharmacy visits, the premium may be worth it. For cost-sensitive patients, generic alternatives deliver the same active ingredients at a fraction of the price.

Strut vs. Compounding-Only Pharmacies

Patients with existing prescriptions can also use independent compounding pharmacies directly. The American College of Clinical Pharmacy published guidelines noting that high-quality compounding pharmacies should hold PCAB accreditation or equivalent state-level quality certifications. Strut's compounding partner pharmacy details are available on their website but are not prominently displayed. Patients who want to verify quality standards should request certificates of analysis for their specific formulations.

Ingredient Safety: What the Evidence Shows for Strut's Core Compounds

The safety profiles of Strut's active ingredients are well-characterized. This is one area where abundant clinical data exists, regardless of Strut's own outcome reporting.

Finasteride Safety

The most debated safety question in Strut's product line involves finasteride. The FDA label for Propecia lists sexual side effects (decreased libido, erectile dysfunction, ejaculation disorder) occurring in 1.3% to 1.8% of men in key trials versus 0.7% to 1.3% for placebo [1]. The "post-finasteride syndrome" hypothesis, describing persistent sexual, neurological, and psychological symptoms after discontinuation, has generated significant online discussion. The Endocrine Society's 2019 clinical practice guideline states: "We suggest against routinely measuring serum dihydrotestosterone in men with suspected androgen deficiency" and notes that finasteride's side effects "resolve upon discontinuation in the vast majority of cases" [12].

A 2021 pharmacovigilance analysis in JAMA Dermatology found that while reports of persistent side effects exist in the FDA Adverse Event Reporting System, the reporting rate does not establish causation and "should be interpreted with caution given the limitations of spontaneous reporting" [13]. Topical finasteride, which Strut primarily uses, may reduce systemic exposure. A randomized crossover study found that topical finasteride 0.25% reduced scalp DHT by 47% while lowering serum DHT by only 25% to 35%, compared to 60% to 70% reduction with oral finasteride [3].

Tretinoin Safety

Tretinoin's side-effect profile is predictable and dose-dependent: erythema, peeling, and photosensitivity are expected in the first 4 to 6 weeks, a phenomenon dermatologists call the "retinoid response" or "retinization period." The Cochrane review found no serious adverse events attributed to topical tretinoin in any included trial [4]. Pregnancy is an absolute contraindication.

PDE5 Inhibitor Safety

Sildenafil and tadalafil carry well-defined contraindications: concurrent nitrate use, severe hepatic impairment, and recent stroke or MI (within 6 months per AHA/ACC guidelines). The most common side effects (headache, flushing, dyspepsia, nasal congestion) occurred in 10% to 16% of patients in the Goldstein trial [6]. For the daily tadalafil 5 mg regimen, which some Strut products approximate, the IIEF pooled analysis reported a discontinuation rate due to adverse events of 3.3% versus 1.8% for placebo [7].

Red Flags to Watch For

Not all compounding telehealth platforms are equal. Patients evaluating Strut or any similar service should look for specific quality signals.

Prescriber Credentials

Verify that the prescribing physician holds an active, unrestricted license in the patient's state. Strut states that all consultations are conducted by licensed providers, but patients should confirm this through their state medical board's license lookup tool.

Compounding Quality

Ask whether the compounding pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB) or holds equivalent state certification. Request beyond-use dating information for compounded products, particularly topical solutions that may have stability limitations.

Outcome Tracking

Platforms that offer standardized progress tracking (photo comparison tools, validated questionnaire scores) provide more useful clinical feedback than those relying solely on patient-initiated messaging. Strut offers some photo-based tracking but does not appear to use validated instruments like the Norwood-Hamilton scale for hair loss staging or the Investigator Global Assessment for acne severity.

The Bottom Line on Strut's Value Proposition

Strut sells convenience and combination formulations built from well-studied active ingredients. The ingredients work. Clinical trials with thousands of participants confirm the efficacy of finasteride, minoxidil, tretinoin, sildenafil, and tadalafil for their respective indications. What remains unproven is whether Strut's specific compounded ratios, its adjunct ingredients, and its care model produce outcomes that match, exceed, or fall short of what those same active ingredients achieve in clinical trials.

For patients who want a single subscription platform covering hair, skin, and sexual health with no pharmacy visits, Strut offers a reasonable option at a moderate price point. For patients focused on cost, generic prescriptions from a primary care physician or another telehealth platform will deliver the same core active ingredients at lower cost. For patients with complex medical histories or atypical presentations, an in-person specialist visit remains the higher-quality starting point.

The American Academy of Dermatology's position statement on teledermatology endorses asynchronous models for "appropriate clinical scenarios" while emphasizing that "teledermatology should not replace in-person care when in-person evaluation is clinically necessary." Patients should apply the same standard to all DTC telehealth platforms, including Strut: use it for straightforward, well-characterized conditions and seek in-person evaluation when results plateau or symptoms change.

Oral finasteride 1 mg daily maintains or improves hair count in 83% of men at 24 months [1], and generic tablets cost under $10/month at most pharmacies.